Black Rock Inc. Spero Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 483,402 shares of SPRO stock, worth $613,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

483,402

Previous 476,896 1.36%

Holding current value

$613,920

Previous $820,000 23.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.27 - $1.8 $8,262 - $11,710	6,506 Added 1.36%	483,402 $628,000
Q1 2024 May 10, 2024	SELL	$1.35 - $1.79 $4,999 - $6,628	-3,703 Reduced 0.77%	476,896 $820,000
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.47 $1,210 - $1,778	-1,210 Reduced 0.25%	480,599 $706,000
Q3 2023 Nov 13, 2023	SELL	$1.2 - $1.63 $50,394 - $68,451	-41,995 Reduced 8.02%	481,809 $582,000
Q2 2023 Aug 11, 2023	BUY	$1.42 - $1.95 $48,267 - $66,282	33,991 Added 6.94%	523,804 $759,000
Q1 2023 May 12, 2023	BUY	$1.35 - $2.0 $2,335 - $3,460	1,730 Added 0.35%	489,813 $710,000
Q4 2022 Feb 13, 2023	SELL	$1.55 - $2.12 $316,285 - $432,596	-204,055 Reduced 29.48%	488,083 $844,000
Q3 2022 Nov 14, 2022	BUY	$0.68 - $2.2 $941 - $3,047	1,385 Added 0.2%	692,138 $1.39 Million
Q2 2022 Aug 12, 2022	SELL	$0.74 - $7.44 $816,462 - $8.21 Million	-1,103,328 Reduced 61.5%	690,753 $513,000
Q1 2022 May 12, 2022	SELL	$7.87 - $15.15 $36,957 - $71,144	-4,696 Reduced 0.26%	1,794,081 $15.6 Million
Q4 2021 Feb 10, 2022	SELL	$13.09 - $18.77 $49,100 - $70,406	-3,751 Reduced 0.21%	1,798,777 $28.8 Million
Q3 2021 Nov 09, 2021	BUY	$13.03 - $19.51 $308,889 - $462,504	23,706 Added 1.33%	1,802,528 $33.2 Million
Q2 2021 Aug 11, 2021	BUY	$12.22 - $15.79 $21.7 Million - $28.1 Million	1,778,822 New	1,778,822 $24.8 Million

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $44.5M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account